Home › Funds › Frazier Life Sciences Management, L.P. › EOLS
Frazier Life Sciences Management, L.P. position in EOLS
EVOLUS INC · Health Care
Frazier Life Sciences Management, L.P. reported holding 2,630,665 shares of EOLS (EVOLUS INC) in its Q2 2026 13F filing — a position valued at US$18.3M, representing 0.40% of its reported portfolio and ranking #35 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed EOLS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s EOLS position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in EOLS in Q2 2025 at 2,435,550 shares (US$22.4M). Across 5 filings, Frazier Life Sciences Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 2,630,665 shares valued at US$18.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 2.44M | $22.43M | New |
| Q3 2025 | 2.63M | $16.15M | Add |
| Q4 2025 | 2.63M | $17.49M | Hold |
| Q1 2026 | 2.63M | $10.81M | Hold |
| Q2 2026 | 2.63M | $18.26M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EOLS and 13F data
EOLS (EVOLUS INC) is a Health Care company. 21 other funds we track also report a position in EOLS — the largest reported positions include Nantahala Capital Management, LLC (US$38.9M), BRAIDWELL LP (US$21.9M), Soviero Asset Management, LP (US$5.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EOLS
- Nantahala Capital Management, LLC 5.60M sh · $38.88M · Q2 2026
- BRAIDWELL LP 3.16M sh · $21.90M · Q2 2026
- Soviero Asset Management, LP 770.00K sh · $5.34M · Q2 2026
- AWH Capital, L.P. 625.00K sh · $4.34M · Q2 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held EOLS?
Frazier Life Sciences Management, L.P. has disclosed EOLS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Frazier Life Sciences Management, L.P.'s current position in EOLS?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 2.63M shares of EOLS (EVOLUS INC), valued at $18.26M, representing 0.40% of its reported portfolio and ranking #35.
Has Frazier Life Sciences Management, L.P. been buying or selling EOLS?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in EOLS.
Which other funds hold EOLS?
Other major institutional holders of EOLS include Nantahala Capital Management, LLC, BRAIDWELL LP, Soviero Asset Management, LP, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.